Randall Stevens is the founder of Centrexion Therapeutics. Centrexion Therapeutics has raised $108M in total funding. Latest round: Growth.
Randall Stevens serves as the Chief Medical Strategist at Centrexion Therapeutics, a late clinical-stage biopharmaceutical company based in Boston, Massachusetts. The company develops novel, non-opioid, and non-addictive therapies for chronic pain, with a focus on both human and veterinary applications. Centrexion Therapeutics has raised a total of $107.5 million across two funding rounds.
Full founder directory · Investor directory · Company funding database · Fundraising library